I don't think that Goodman are in a position to buy IIF. I don't think that they have the money on their own, unless they do a JV. IMO
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025